ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments
L. Robado de Lope, R. Serna-Blasco,P. Mediavilla,S. Sanz-Moreno,A. Rodriguez-Festa,P. Gallego-Gil,C. Flores,V. Calvo,A. Collazo-Lorduy,M. Blanco,S. Pena Cabia,P. Diz Tain,M. L. Garrido Onecha,A. Sanchez-Hernandez,S. Sequero Lopez,J. Rogado,J. Coves Sarto,A. Lopez Martin,X. Mielgo,S. Vazquez Estevez, V. Gonzalez-Rumayor, A. Romero, M. Provencio JOURNAL OF THORACIC ONCOLOGY（2023）
关键词
Biomarkers,Immunotherapy,NSCLC
AI 理解论文
溯源树
样例
